Assure Holdings Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS EQUITY (DEFICIT) - Additional Information (Details)

SHAREHOLDERS EQUITY (DEFICIT) - Additional Information (Details) $ / shares in Units, $ in Thousands		1 Months Ended					3 Months Ended		9 Months Ended
	Aug. 16, 2023	Nov. 30, 2023	Aug. 31, 2023 shares	Jun. 30, 2023 shares	May 31, 2023 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) shares	Dec. 31, 2022 $ / shares shares
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Common stock, shares authorized							9,000,000	180,000,000	9,000,000	180,000,000	9,000,000
Price per share \| $ / shares					$ 1.20
Pre-funded warrants					750,000
Pre-funded warrants, shares			750,000
Common stock, par value (in dollars per share) \| $ / shares						$ 0.001	$ 0.001		$ 0.001		$ 0.001
General corporate purposes, including working capital, marketing, and capital expenditures \| $							$ 5,100
Common shares to certain employees, directors and vendors in lieu of cash compensation				59,748
Common stock, shares issued							6,720,460		6,720,460		1,051,098
Common stock, shares outstanding							6,720,460		6,720,460		1,051,098
Fractional shares issued related to reverse split (shares)						9,000,000
Reverse stock split ratio						0.05
Fractional shares issued						0
Gross proceeds \| $								$ 5,195	$ 5,383	$ 5,195
Number of Warrants Exercised									(750,000)
Period to submit plan to regain compliance	45 days
Subsequent Events
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Period to submit plan to regain compliance		45 days
Amended Stock Option Plan
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Common stock, shares outstanding							31,859		31,859
Equity Incentive Plan
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Common stock, shares outstanding							11,500		11,500
Number of shares authorized							88,500		88,500
Private Placements
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Shares issued						50,000
Shares issue price \| $ / shares						$ 6.00
Gross proceeds \| $						$ 300
Public offering (pre-funded warrants)
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Underwritten public offering, number of shares					5,000,000
Price per share \| $ / shares					$ 1.199
Warrant exercise price (in dollars per share) \| $ / shares					$ 0.001
Gross proceeds \| $					$ 6,000
Option to purchase additional shares
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Underwritten public offering, number of shares					750,000
Number of days to purchase additional shares					45 days
Common Stock
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Pre-funded warrants, shares							750,000		750,000
Share issuance, acquisition related (in shares)							547,946		547,946
Fractional shares issued related to reverse split (shares)									11,168
Shares issued								278,804	4,091,667	278,804
Gross proceeds \| $								$ 6	$ 5	$ 6
Additional paid-in capital
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Gross proceeds \| $								$ 5,189	$ 5,378	$ 5,189
Acquisition of Certain Assets of Innovation Neuromonitoring, LLC
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Share issuance, acquisition related (in shares)			547,946